Showing results (21-30 of 135) with videos related to
Sort By:
Pageof 14
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2003
Hepatic drug metabolism and transport in patients with kidney diseaseThomas D Nolin, Reginald F Frye, Gary R MatzkePharmacological Reviews|June 21, 2015
Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsDustin R Walsh, Thomas D Nolin, Peter A FriedmanDrug Metabolism Letters|August 19, 2015
Downregulation of Hepatic Carbonyl Reductase Type 1 in End-Stage Renal DiseaseOsama Y Alshogran, Bradley L Urquhart, Thomas D NolinAdvances in Chronic Kidney Disease|July 9, 2010
Nocturia and aging: diagnosis and treatmentSarinya Boongird, Nirav Shah, Thomas D Nolin, et al.Journal of Clinical Pharmacology|January 11, 2012
Current understanding of drug disposition in kidney diseaseJudith Naud, Thomas D Nolin, Francois A Leblond, et al.Advances in Chronic Kidney Disease|May 3, 2011
Blood purification in toxicology: nephrology's ugly ducklingMarc Ghannoum, Thomas D Nolin, Valery Lavergne, et al.Journal of General Internal Medicine|April 28, 2010
Primary care of the renal transplant patientGaurav Gupta, Mark L Unruh, Thomas D Nolin, et al.Clinical Journal of the American Society of Nephrology : CJASN|September 4, 2014
Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKDJason R Stubbs, Shiqin Zhang, Peter A Friedman, et al.Journal of Pharmaceutical and Biomedical Analysis|May 4, 2024
Development and validation of an UPLC-MS/MS method for the simultaneous determination of fexofenadine and olmesartan in human serum: Application to in vivo pharmacokinetic studiesRaymond E West, Junmei Zhang, Melanie S Joy, et al.Seminars in Dialysis|May 15, 2014
Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practiceMarc Ghannoum, Josée Bouchard, Thomas D Nolin, et al.Pageof 14